Cite
HARVARD Citation
Strong, J. et al. (2022). Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma. American surgeon. 88 (6), pp. 1153-1158. [Online].